INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP)

CUSIP: 46137V662

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / PHARMACEUTICALS
Total 13F shares
638,030
Share change
-274
Total reported value
$59,014,643
Price per share
$92.49
Number of holders
93
Value change
+$125,900
Number of buys
27
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 46137V662?
CUSIP 46137V662 identifies PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q3 2025

As of 30 Sep 2025, INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 638,030 shares. The largest 10 holders included Peak Asset Management, LLC, LPL Financial LLC, UBS Group AG, MORGAN STANLEY, ROYAL BANK OF CANADA, GOLDMAN SACHS GROUP INC, BANK OF AMERICA CORP /DE/, Joseph Group Capital Management, MGB Wealth Management, LLC, and WELLS FARGO & COMPANY/MN. This page lists 93 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.